Product Description: Anandamide-d11 is deuterium labeled Anandamide. Anandamide is an immune modulator in the central nervous system acts via not only cannabinoid receptors (CB1 and CB2) but also other targets (e.g., GPR18/GPR55)[1][2].
Applications: COVID-19-immunoregulation
Formula: C22H26D11NO2
References: [1]Malek N, et al. Anandamide, Acting via CB2 Receptors, Alleviates LPS-Induced Neuroinflammation in Rat Primary Microglial Cultures. Neural Plast. 2015;2015:130639./[2]Troy-Fioramonti S, et al. Acute activation of cannabinoid receptors by Anandamide reduces gastrointestinal motility and improves postprandial glycemia in mice. Diabetes. 2015 Mar;64(3):808-18./[3]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-223.
CAS Number: 2260669-86-9
Molecular Weight: 358.60
Research Area: Inflammation/Immunology
Solubility: 10 mM in DMSO
Target: Cannabinoid Receptor;Endogenous Metabolite;GPR55;Isotope-Labeled Compounds
Deutsch
English
